Updated:
BroadOak Capital Partners
BroadOak Capital Partners is a Bethesda-based private equity firm with a disclosed multi-stage mandate spanning divestiture, venture, and venture debt.
BroadOak Capital Partners
BroadOak Capital Partners is a boutique financial institution providing direct investment and banking services to life sciences and biopharma services companies
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Bethesda
Corporate office
Bethesda, MD, United States
Frequently asked questions
What investment stages does BroadOak Capital Partners target?
The firm's self-reported strategy spans divestitures, early-stage, late-stage/growth, general venture, and venture debt. This multi-stage mandate is unusually broad. No public details clarify whether these stages are executed through separate funds or a single flexible vehicle.
Who runs investment decisions at BroadOak Capital Partners?
No principals or investment committee members are publicly identified by the firm or through regulatory filings. As a result, the individuals responsible for capital allocation remain unknown.
Does BroadOak Capital Partners participate in fund commitments or only direct deals?
The firm has not disclosed whether it makes fund commitments or exclusively pursues direct investments and venture debt. Its stated strategy offers no clarity on this structural point.
How does BroadOak source proprietary deal flow?
With no disclosed principals, portfolio companies, or sector focus, the firm's sourcing model cannot be assessed. No public record indicates a specific origination advantage or network-driven approach.
What is BroadOak Capital Partners' known posture on co-investments alongside external GPs?
BroadOak has not made any public statement regarding co-investment practices. Without a disclosed track record or investor base, its willingness to co-invest alongside other managers is unknown.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: